1. Are dendritic cells the most appropriate therapeutic vaccine for patients with ovarian cancer?. (October 2020) Authors: Martin-Lluesma, Silvia; Graciotti, Michele; Grimm, Alizée J; Boudousquié, Caroline; Chiang, Cheryl L; Kandalaft, Lana E Journal: Current opinion in biotechnology Issue: Volume 65(2020) Page Start: 190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chemical Genetic Screen Identifies Natural Products that Modulate Centriole Number. (23rd September 2016) Authors: Graciotti, Michele; Fang, Zhou; Johnsson, Kai; Gönczy, Pierre Journal: Chembiochem Issue: Volume 17:Number 21(2016) Page Start: 2063 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Editorial overview: Pharmaceutical biotechnology: new frontiers in cancer immunotherapy. (October 2020) Authors: Kandalaft, Lana E; Graciotti, Michele Journal: Current opinion in biotechnology Issue: Volume 65(2020) Page Start: iii Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Electroporation as a method of choice to generate genetically modified dendritic cell cancer vaccines. (October 2020) Authors: Ahmed, Rita; Sayegh, Naya; Graciotti, Michele; Kandalaft, Lana E. Journal: Current opinion in biotechnology Issue: Volume 65(2020) Page Start: 142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗